Detalhe da pesquisa
1.
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.
Nat Immunol
; 23(8): 1183-1192, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902637
2.
Fundamental immune-oncogenicity trade-offs define driver mutation fitness.
Nature
; 606(7912): 172-179, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545680
3.
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial.
Lancet Oncol
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740030
4.
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.
N Engl J Med
; 384(22): 2102-2114, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077643
5.
Integration of peripheral blood- and tissue-based biomarkers of response to immune checkpoint blockade in urothelial carcinoma.
J Pathol
; 261(3): 349-360, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37667855
6.
Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors.
Cancer
; 129(24): 3952-3961, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715631
7.
Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma.
J Urol
; 209(5): 863-871, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724067
8.
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summary.
Future Oncol
; 19(6): 413-426, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919916
9.
Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.
Jpn J Clin Oncol
; 53(1): 16-25, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36300304
10.
Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitness.
Nature
; 606(7914): E5, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641605
11.
Survival Impact of Variant Histology Diagnosis in Upper Tract Urothelial Carcinoma.
J Urol
; 208(4): 813-820, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686817
12.
Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy.
BJU Int
; 129(4): 463-469, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33866683
13.
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
Lancet Oncol
; 22(7): 919-930, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051177
14.
Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma.
Br J Cancer
; 124(7): 1214-1221, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33473164
15.
Four Cycles of Etoposide plus Cisplatin for Patients with Good-Risk Advanced Germ Cell Tumors.
Oncologist
; 26(6): 483-491, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586274
16.
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
Cancer
; 126(11): 2597-2606, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208524
17.
A phase 2 trial of buparlisib in patients with platinum-resistant metastatic urothelial carcinoma.
Cancer
; 126(20): 4532-4544, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767682
18.
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
N Engl J Med
; 376(11): 1015-1026, 2017 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28212060
19.
Utility of Routine Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/Computerized Tomography in Identifying Pathological Lymph Node Metastases at Radical Cystectomy.
J Urol
; 204(2): 254-259, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32134343
20.
Trends in Management and Outcomes among Patients with Urothelial Carcinoma Undergoing Radical Cystectomy from 1995 to 2015: The Memorial Sloan Kettering Experience.
J Urol
; 204(4): 677-684, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294398